Brief: Theriva Biologics Reports Third Quarter 2022 Operational Highlights And Financial Results
10/11/2022 22:34
Nov 10 (Reuters) - Theriva Biologics Inc TOVX.A :
* THERIVA BIOLOGICS REPORTS THIRD QUARTER 2022 OPERATIONAL
HIGHLIGHTS AND FINANCIAL RESULTS
* THERIVA BIOLOGICS INC - AS OF SEPTEMBER 30, CO REPORTS
$50.5
MILLION IN CASH, WHICH IS EXPECTED TO PROVIDE RUNWAY INTO Q1 OF
2024
* THERIVA BIOLOGICS INC - QTRLY LOSS PER SHARE $0.33
Source text for Eikon: ID:nGNXTjn9X
Further company coverage: TOVX.A
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Theriva Biologics
See all newsTheriva Biologics Q2 net loss narrows on lower R&D costs, expenses
Brief: Theriva™ Biologics Announces Upcoming Presentation Of Additional Data From The Virage Phase 2B Clinical Trial Of Vcn-01 In Metastatic Pancreatic Cancer At Aacr 2026 Annual Meeting
Brief: Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications
Brief: Theriva Biologics Implements 32% Workforce Reduction - SEC Filing
Brief: Theriva™ Biologics Announces Presentation Of Data From Vcn-01 Retinoblastoma Phase 1 Clinical Trial At Asco 2025